Trials / Conditions / Drug Drug Interaction (DDI)

Drug Drug Interaction (DDI)

14 registered clinical trials studyying Drug Drug Interaction (DDI) — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study on the Drug Interaction Between Buagafuran and Voriconazole NCT07457203	Beijing Union Pharmaceutical Factory Ltd	Phase 1
Recruiting	to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogre NCT07265466	Onconic Therapeutics Inc.	Phase 1
Active Not Recruiting	Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy Subjects NCT07196449	Seoul National University Bundang Hospital	Phase 1
Completed	A Open-label, Drug-Drug Interaction With SB_MDZ in Healty Adult Subjects NCT06846684	SPARK Biopharma	Phase 1
Completed	A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazol NCT06847464	Enanta Pharmaceuticals, Inc	Phase 1
Recruiting	Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination NCT06733675	Basilea Pharmaceutica	Phase 1
Active Not Recruiting	A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Pro NCT06632990	Allyx Therapeutics	Phase 1
Completed	Drug-Drug Interaction (DDI) Study for TD-9855 NCT03432793	Theravance Biopharma	Phase 1
Completed	Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentration NCT02169713	Astellas Pharma Europe B.V.	Phase 1
Completed	Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy S NCT02127034	Astellas Pharma Europe B.V.	Phase 1
Completed	A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in NCT02138799	Astellas Pharma Europe B.V.	Phase 1
Completed	A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Mal NCT02083627	Astellas Pharma Europe B.V.	Phase 1
Completed	A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the E NCT01797198	Astellas Pharma Europe B.V.	Phase 1
Completed	A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosi NCT01943487	Astellas Pharma Europe B.V.	Phase 1